Biotech · Private company · Chicago, IL, US
Inomagen Therapeutics, Inc
Track this companyFree. Adds Inomagen Therapeutics, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- A New and Disruptive Gene Based Therapy for Atrial FibrillationFiscal year 2026 · $1.4MNIH RePORTER 1R44HL187127-01 · fetched Nov 12, 2026